Panakès Launches €8.5M Lombardy Biotech Fund

Panakès Partners has launched an €8.5 million investment vehicle focused on MedTech and biotech companies in Italy's Lombardy region.

What happened

The vehicle is backed by Lombardia Venture STEP, a regional programme supported by European development funding and managed by Finlombarda. It will invest in early-stage healthcare companies with a focus on medical technology and biotechnology. The fund is much smaller than major global healthcare vehicles but is designed for a different purpose: supporting regional company formation and commercialisation around universities, hospitals and research centres.

Why it matters

Life-science ecosystems depend heavily on local infrastructure and investors that understand scientific spinouts. Regional capital can help researchers bridge the gap between academic work and venture-backed companies before larger international investors are willing to participate.

The bigger picture

The fund is a modest financing vehicle, but it highlights Europe's effort to build deeper local innovation ecosystems rather than rely only on a small number of large hubs. Its impact will depend on the quality of companies created and whether follow-on capital is available as they scale.